You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Hexaminolevulinate hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for hexaminolevulinate hydrochloride and what is the scope of patent protection?

Hexaminolevulinate hydrochloride is the generic ingredient in one branded drug marketed by Photocure Asa and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Hexaminolevulinate hydrochloride has twenty-nine patent family members in seventeen countries.

One supplier is listed for this compound.

Summary for hexaminolevulinate hydrochloride
International Patents:29
US Patents:3
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 74
Clinical Trials: 11
Patent Applications: 246
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in hexaminolevulinate hydrochloride?hexaminolevulinate hydrochloride excipients list
DailyMed Link:hexaminolevulinate hydrochloride at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for hexaminolevulinate hydrochloride
Generic Entry Date for hexaminolevulinate hydrochloride*:
Constraining patent/regulatory exclusivity:
Dosage:
FOR SOLUTION;INTRAVESICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for hexaminolevulinate hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
KARL STORZ Endoscopy-America, Inc.Phase 2
Dr. Te VuongPhase 2
Oslo University HospitalPhase 2/Phase 3

See all hexaminolevulinate hydrochloride clinical trials

US Patents and Regulatory Information for hexaminolevulinate hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for hexaminolevulinate hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 ⤷  Try a Trial ⤷  Try a Trial
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 ⤷  Try a Trial ⤷  Try a Trial
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 ⤷  Try a Trial ⤷  Try a Trial
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for hexaminolevulinate hydrochloride

Country Patent Number Title Estimated Expiration
South Korea 20180094986 방광암에 대한 광역학 요법 (PDT)의 방법 ⤷  Try a Trial
Israel 259925 שיטת טיפול פוטודינמי עבור סרטן שלפוחית השתן (Method of photodynamic therapy (pdt) for bladder cancer) ⤷  Try a Trial
Japan 2019501161 膀胱癌に対する光線力学的療法(PDT)の方法 ⤷  Try a Trial
Chile 2018001612 Método de terapia fotodinámica (pdt) para el cáncer de vejiga ⤷  Try a Trial
European Patent Office 3389716 PROCÉDÉ DE THÉRAPIE PHOTODYNAMIQUE (PDT) POUR LE CANCER DE LA VESSIE (METHOD OF PHOTODYNAMIC THERAPY (PDT) FOR BLADDER CANCER) ⤷  Try a Trial
China 108601836 用于膀胱癌的新辅助疗法 (Neoadjuvant therapy for bladder cancer) ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.